晚期卵巢癌间歇性细胞减灭术的偏好与考量:患者视角
研究纳入85例计划行间歇性细胞减灭术的晚期卵巢癌患者,通过问卷和情境研究调查其对手术成功率、生存获益及变为依赖照护对决策的影响。结果显示生存获益、手术成功率和依赖照护是重要因素,而并发症和造口风险相对次要,老年患者更重视这些因素。
要点
- 37%患者认为无论生存获益如何间歇性细胞减灭术都值得做,39%认为无论手术成功率如何都值得做。
- 41%患者仅在生存获益>12个月时认为手术值得,49%在手术成功率≥25%时认为值得。
- 27%患者认为永久依赖居家照护不可接受,情境研究中并发症和造口风险较手术成功率和生存获益次要。
核心结论
- 生存获益、手术成功率和变为依赖照护是患者决定是否行间歇性细胞减灭术的重要因素,而并发症风险和造口相对次要。
- 研究结果有助于卵巢癌间歇性细胞减灭术的共享决策。
研究设计与样本
- 对计划行间歇性细胞减灭术的晚期卵巢癌患者进行问卷调查,包括情境研究,患者反复在两种治疗方案间选择,方案在手术成功率、生存获益和并发症(包括造口)风险水平上不同。
- 共纳入85例患者,情境研究纳入72例;分析患者偏好,包括年龄<70岁与≥70岁患者的差异。
主要发现
- 85例患者中,31例(37%)认为无论生存获益如何间歇性细胞减灭术都值得,33例(39%)认为无论手术成功率如何都值得。
- 34例(41%)仅在生存获益>12个月时认为手术值得,41例(49%)在手术成功率≥25%时认为值得。
- 27%的患者认为永久依赖居家照护不可接受;老年患者更重视这些因素。
- 情境研究(n=72)中,并发症风险和造口被认为较手术成功率和生存获益次要。
关键数值与推荐
- 37%患者认为无论生存获益如何间歇性细胞减灭术都值得。
- 39%患者认为无论手术成功率如何间歇性细胞减灭术都值得。
- 41%患者仅在生存获益>12个月时认为手术值得。
- 49%患者在手术成功率≥25%时认为手术值得。
- 27%患者认为永久依赖居家照护不可接受。
临床怎么用
- 研究结果可用于卵巢癌间歇性细胞减灭术的共享决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment of advanced-stage ovarian cancer contains cytoreductive surgery (CRS) and chemotherapy. Achieving successful CRS (≤ 1 cm residual disease) is prognostically important, but may not be feasible peri-operatively while still risking complications. Therefore, patients' treatment expectations are important to discuss. We investigated patient considerations for interval CRS. METHODS: Patients with advanced-stage ovarian cancer planned for interval CRS completed a questionnaire about the impact of chance of successful CRS, survival benefit and becoming care-dependent on decision-making regarding CRS. The questionnaire included a vignette study, in which patients repeatedly chose between two treatment scenarios with varying levels for chance of successful CRS, survival benefit and risk of complications including stoma. Patient preferences were analyzed, including differences between patients aged < 70 and ≥ 70 years. RESULTS: Among 85 included patients, 31 (37%) patients considered interval CRS worthwhile irrespective of survival benefit and 33 (39%) irrespective of chance of successful surgery. However, 34 patients (41%) considered interval CRS only worthwhile if survival benefit was > 12 months, while 41 (49%) thought so if chance of successful surgery was ≥ 25%. Older patients considered these factors more important. Overall, 27% considered becoming permanently dependent of home care unacceptable. In the vignette study (n = 72) risk of complications and stoma were considered less important than chance of successful CRS and survival benefit. CONCLUSION: Survival benefit, chance of successful surgery and becoming care-dependent are important factors in patient's decision for interval CRS, while risk of complications and stoma are less important. Our results are useful in shared decision-making for interval CRS in ovarian cancer.
引用
- Lof P, van Soolingen NJ, Piek JMJ, et al. Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective. Gynecol Oncol. 2024. PMID: 38823307. doi:10.1016/j.ygyno.2024.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。